{"id": "IEPA.d2.s2_IEPA.d2.s2.p3", "text": "SP ewes also had greater incorporation of [3H]inositol into inositol trisphosphate (IP3) (+3449%, p less than 0.01) and total inositol phosphate (IP) (+760%, p less than 0.08), in response to oxytocin, than did oCSP ewes (+553 and +168% for IP3 and total IP, respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16", "text_with_entity_marker": "SP ewes also had greater incorporation of [3H]inositol into [E1]inositol trisphosphate[/E1] (IP3) (+3449%, p less than 0.01) and total inositol phosphate (IP) (+760%, p less than 0.08), in response to oxytocin, than did oCSP ewes (+553 and +168% for IP3 and total [E2]IP[/E2], respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "inositol trisphosphate", "entity_1_idx": [[60, 82]], "entity_1_idx_in_text_with_entity_marker": [64, 86], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP", "entity_2_idx": [[255, 257]], "entity_2_idx_in_text_with_entity_marker": [268, 270], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d2.s2_IEPA.d2.s2.p5", "text": "SP ewes also had greater incorporation of [3H]inositol into inositol trisphosphate (IP3) (+3449%, p less than 0.01) and total inositol phosphate (IP) (+760%, p less than 0.08), in response to oxytocin, than did oCSP ewes (+553 and +168% for IP3 and total IP, respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16", "text_with_entity_marker": "SP ewes also had greater incorporation of [3H]inositol into inositol trisphosphate (IP3) (+3449%, p less than 0.01) and total [E1]inositol phosphate[/E1] (IP) (+760%, p less than 0.08), in response to oxytocin, than did oCSP ewes (+553 and +168% for [E2]IP3[/E2] and total IP, respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "inositol phosphate", "entity_1_idx": [[126, 144]], "entity_1_idx_in_text_with_entity_marker": [130, 148], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP3", "entity_2_idx": [[241, 244]], "entity_2_idx_in_text_with_entity_marker": [254, 257], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d2.s3_IEPA.d2.s3.p2", "text": "These results indicate that oTP-1 may prevent luteolysis by inhibiting development of endometrial responsiveness to oxytocin and, therefore, reduce oxytocin-induced synthesis of IP3 and PGF2 alpha", "text_with_entity_marker": "These results indicate that oTP-1 may prevent luteolysis by inhibiting development of endometrial responsiveness to oxytocin and, therefore, reduce [E1]oxytocin[/E1]-induced synthesis of [E2]IP3[/E2] and PGF2 alpha", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[148, 156]], "entity_1_idx_in_text_with_entity_marker": [152, 160], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP3", "entity_2_idx": [[178, 181]], "entity_2_idx_in_text_with_entity_marker": [191, 194], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d9.s20_IEPA.d9.s20.p0", "text": "Pretreatment with pertussis toxin (PTX, 1 microgram/ml) for 2 hr failed to alter the OT-induced increase in [Ca2+]i and IP3 formation", "text_with_entity_marker": "Pretreatment with pertussis toxin (PTX, 1 microgram/ml) for 2 hr failed to alter the [E1]OT[/E1]-induced increase in [Ca2+]i and [E2]IP3[/E2] formation", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "OT", "entity_1_idx": [[85, 87]], "entity_1_idx_in_text_with_entity_marker": [89, 91], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP3", "entity_2_idx": [[120, 123]], "entity_2_idx_in_text_with_entity_marker": [133, 136], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d11.s28_IEPA.d11.s28.p2", "text": "The phospholipase C inhibitor U 71322 prevented the activation of phospholipase C by A beta P", "text_with_entity_marker": "The phospholipase C inhibitor U 71322 prevented the activation of [E1]phospholipase C[/E1] by [E2]A beta P[/E2]", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "phospholipase C", "entity_1_idx": [[66, 81]], "entity_1_idx_in_text_with_entity_marker": [70, 85], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "A beta P", "entity_2_idx": [[85, 93]], "entity_2_idx_in_text_with_entity_marker": [98, 106], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d22.s46_IEPA.d22.s46.p4", "text": "Once the abnormally phosphorylated abnormal prion protein isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular prion protein isoform that aggregates to abnormally phosphorylated abnormal prion protein isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a prion protein-specific kinase", "text_with_entity_marker": "Once the abnormally phosphorylated abnormal prion protein isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular [E1]prion protein[/E1] isoform that aggregates to abnormally phosphorylated abnormal [E2]prion protein[/E2] isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a prion protein-specific kinase", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "prion protein", "entity_1_idx": [[193, 206]], "entity_1_idx_in_text_with_entity_marker": [197, 210], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "prion protein", "entity_2_idx": [[269, 282]], "entity_2_idx_in_text_with_entity_marker": [282, 295], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d23.s47_IEPA.d23.s47.p4", "text": "The resulting abnormally phosphorylated PrPsc aggregates to freshly synthesized PrPc, transforming it into same; due to a system of positive feedback invoked by the organophosphate-induced blockage of a prion protein-specific protein kinase.", "text_with_entity_marker": "The resulting abnormally phosphorylated PrPsc aggregates to freshly synthesized [E1]PrPc[/E1], transforming it into same; due to a system of positive feedback invoked by the organophosphate-induced blockage of a prion protein-specific [E2]protein kinase[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PrPc", "entity_1_idx": [[80, 84]], "entity_1_idx_in_text_with_entity_marker": [84, 88], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase", "entity_2_idx": [[226, 240]], "entity_2_idx_in_text_with_entity_marker": [239, 253], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d28.s60_IEPA.d28.s60.p0", "text": "In HVSMC both oxytocin and AVP increased inositol 1,4,5-trisphosphate (IP3) production and [Ca2+]i response, but the efficacy of the responses was greater for oxytocin than AVP", "text_with_entity_marker": "In HVSMC both [E1]oxytocin[/E1] and AVP increased [E2]inositol 1,4,5-trisphosphate[/E2] (IP3) production and [Ca2+]i response, but the efficacy of the responses was greater for oxytocin than AVP", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[14, 22]], "entity_1_idx_in_text_with_entity_marker": [18, 26], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "inositol 1,4,5-trisphosphate", "entity_2_idx": [[41, 69]], "entity_2_idx_in_text_with_entity_marker": [54, 82], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d28.s60_IEPA.d28.s60.p2", "text": "In HVSMC both oxytocin and AVP increased inositol 1,4,5-trisphosphate (IP3) production and [Ca2+]i response, but the efficacy of the responses was greater for oxytocin than AVP", "text_with_entity_marker": "In HVSMC both oxytocin and AVP increased [E1]inositol 1,4,5-trisphosphate[/E1] (IP3) production and [Ca2+]i response, but the efficacy of the responses was greater for [E2]oxytocin[/E2] than AVP", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "inositol 1,4,5-trisphosphate", "entity_1_idx": [[41, 69]], "entity_1_idx_in_text_with_entity_marker": [45, 73], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[159, 167]], "entity_2_idx_in_text_with_entity_marker": [172, 180], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d32.s67_IEPA.d32.s67.p0", "text": "Previous studies have demonstrated that the nitric oxide (NO) synthase inhibitor L-NAME exerts positive effects on the arginine vasopressin (AVP) and oxytocin (OT) responses to insulin-induced hypoglycemia, suggesting inhibitory actions of NO", "text_with_entity_marker": "Previous studies have demonstrated that the nitric oxide (NO) synthase inhibitor L-NAME exerts positive effects on the arginine vasopressin (AVP) and [E1]oxytocin[/E1] (OT) responses to [E2]insulin[/E2]-induced hypoglycemia, suggesting inhibitory actions of NO", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[150, 158]], "entity_1_idx_in_text_with_entity_marker": [154, 162], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[177, 184]], "entity_2_idx_in_text_with_entity_marker": [190, 197], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d34.s81_IEPA.d34.s81.p0", "text": "To establish the cell type expressing leptin, we also assessed the size and organization of lipid droplets, the ultrastructural features of mitochondria, and the presence or absence of uncoupling protein, a brown fat-specific marker", "text_with_entity_marker": "To establish the cell type expressing [E1]leptin[/E1], we also assessed the size and organization of lipid droplets, the ultrastructural features of mitochondria, and the presence or absence of [E2]uncoupling protein[/E2], a brown fat-specific marker", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[38, 44]], "entity_1_idx_in_text_with_entity_marker": [42, 48], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling protein", "entity_2_idx": [[185, 203]], "entity_2_idx_in_text_with_entity_marker": [198, 216], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d39.s94_IEPA.d39.s94.p0", "text": "Insulin was conjugated to phospholipase C by a three-step procedure with hetero-bifunctional crosslinking reagents, succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate and 3-(2-pyridyldithio)propionic acid N-hydroxysuccinimide ester", "text_with_entity_marker": "[E1]Insulin[/E1] was conjugated to [E2]phospholipase C[/E2] by a three-step procedure with hetero-bifunctional crosslinking reagents, succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate and 3-(2-pyridyldithio)propionic acid N-hydroxysuccinimide ester", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Insulin", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[26, 41]], "entity_2_idx_in_text_with_entity_marker": [39, 54], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d40.s99_IEPA.d40.s99.p1", "text": "These data indicate that an adequate level of GTP is critical for glucose's potentiation of Ca(2+)-induced insulin secretion in primed islets but that PLC activation can clearly be dissociated from insulin secretion and therefore cannot be the major cause of glucose's augmentation of Ca(2+)-induced insulin secretion", "text_with_entity_marker": "These data indicate that an adequate level of GTP is critical for glucose's potentiation of Ca(2+)-induced [E1]insulin[/E1] secretion in primed islets but that PLC activation can clearly be dissociated from [E2]insulin[/E2] secretion and therefore cannot be the major cause of glucose's augmentation of Ca(2+)-induced insulin secretion", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[107, 114]], "entity_1_idx_in_text_with_entity_marker": [111, 118], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[198, 205]], "entity_2_idx_in_text_with_entity_marker": [211, 218], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d43.s108_IEPA.d43.s108.p0", "text": "Induction by leptin of uncoupling protein-2 and enzymes of fatty acid oxidation", "text_with_entity_marker": "Induction by [E1]leptin[/E1] of [E2]uncoupling protein-2[/E2] and enzymes of fatty acid oxidation", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[13, 19]], "entity_1_idx_in_text_with_entity_marker": [17, 23], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling protein-2", "entity_2_idx": [[23, 43]], "entity_2_idx_in_text_with_entity_marker": [36, 56], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d43.s111_IEPA.d43.s111.p0", "text": "By directly regulating the expression of enzymes of free fatty acid metabolism and of UCP-2, leptin controls intracellular triglyceride content of certain nonadipocytes, as well as adipocytes", "text_with_entity_marker": "By directly regulating the expression of enzymes of free fatty acid metabolism and of [E1]UCP-2[/E1], [E2]leptin[/E2] controls intracellular triglyceride content of certain nonadipocytes, as well as adipocytes", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UCP-2", "entity_1_idx": [[86, 91]], "entity_1_idx_in_text_with_entity_marker": [90, 95], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[93, 99]], "entity_2_idx_in_text_with_entity_marker": [106, 112], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d48.s125_IEPA.d48.s125.p1", "text": "These data demonstrate a leptin-induced increase in energy expenditure in nonmutant rodents and suggest that one mechanism by which leptin increases energy expenditure is through increased thermogenesis in BAT, including increased expression of UCP", "text_with_entity_marker": "These data demonstrate a [E1]leptin[/E1]-induced increase in energy expenditure in nonmutant rodents and suggest that one mechanism by which leptin increases energy expenditure is through increased thermogenesis in BAT, including increased expression of [E2]UCP[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[25, 31]], "entity_1_idx_in_text_with_entity_marker": [29, 35], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP", "entity_2_idx": [[245, 248]], "entity_2_idx_in_text_with_entity_marker": [258, 261], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d57.s147_IEPA.d57.s147.p1", "text": "Despite the low levels of insulin-induced PLC activity, insulin-stimulated glucose transport activity was similarly inhibited by U73122 (55.9 +/- 13.1% inhibition)", "text_with_entity_marker": "Despite the low levels of [E1]insulin[/E1]-induced PLC activity, [E2]insulin[/E2]-stimulated glucose transport activity was similarly inhibited by U73122 (55.9 +/- 13.1% inhibition)", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[26, 33]], "entity_1_idx_in_text_with_entity_marker": [30, 37], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[56, 63]], "entity_2_idx_in_text_with_entity_marker": [69, 76], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d57.s148_IEPA.d57.s148.p1", "text": "Inhibition of PLC activation did not impair either EGF- or insulin-induced activation of glycogen synthase or incorporation of glucose into lipid, supporting the hypothesis that both EGF- and insulin-induced glucose disposal can be independent of GLUT4-mediated glucose transport.", "text_with_entity_marker": "Inhibition of [E1]PLC[/E1] activation did not impair either EGF- or insulin-induced activation of glycogen synthase or incorporation of glucose into lipid, supporting the hypothesis that both EGF- and [E2]insulin[/E2]-induced glucose disposal can be independent of GLUT4-mediated glucose transport.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PLC", "entity_1_idx": [[14, 17]], "entity_1_idx_in_text_with_entity_marker": [18, 21], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[192, 199]], "entity_2_idx_in_text_with_entity_marker": [205, 212], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d58.s153_IEPA.d58.s153.p1", "text": "We conclude that: (1) AVP causes a rapid, and reversible, phosphorylation of the MARCKS protein in the ovine anterior pituitary; (2) since the AVP-induced increase in MARCKS phosphorylation occurs much earlier in these cells than does PKC trans-location, MARCKS phosphorylation may provide a more sensitive index of the onset of PKC activation than the translocation assay; (3) the close temporal association between MARCKS phosphorylation and the rapid early release of ACTH suggests that MARCKS phosphorylation may be involved in the initial intracellular events that underly exocytosis of the hormone.", "text_with_entity_marker": "We conclude that: (1) [E1]AVP[/E1] causes a rapid, and reversible, phosphorylation of the MARCKS protein in the ovine anterior pituitary; (2) since the AVP-induced increase in MARCKS phosphorylation occurs much earlier in these cells than does [E2]PKC[/E2] trans-location, MARCKS phosphorylation may provide a more sensitive index of the onset of PKC activation than the translocation assay; (3) the close temporal association between MARCKS phosphorylation and the rapid early release of ACTH suggests that MARCKS phosphorylation may be involved in the initial intracellular events that underly exocytosis of the hormone.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AVP", "entity_1_idx": [[22, 25]], "entity_1_idx_in_text_with_entity_marker": [26, 29], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PKC", "entity_2_idx": [[235, 238]], "entity_2_idx_in_text_with_entity_marker": [248, 251], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d59.s154_IEPA.d59.s154.p0", "text": "PKB, which is an important early PI 3-kinase-dependent component of insulin signalling pathways, is also down-regulated by PLC-coupled agonists", "text_with_entity_marker": "PKB, which is an important early PI 3-kinase-dependent component of [E1]insulin[/E1] signalling pathways, is also down-regulated by [E2]PLC[/E2]-coupled agonists", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[68, 75]], "entity_1_idx_in_text_with_entity_marker": [72, 79], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLC", "entity_2_idx": [[123, 126]], "entity_2_idx_in_text_with_entity_marker": [136, 139], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d60.s155_IEPA.d60.s155.p0", "text": "The activity of the MAPKs, induced by AVP or PMA was inhibited by downregulation of protein kinase C (PKC), by the tyrosine kinase inhibitor genistein and by MAPK kinase (MEK) inhibitor, PD98059", "text_with_entity_marker": "The activity of the MAPKs, induced by [E1]AVP[/E1] or PMA was inhibited by downregulation of [E2]protein kinase C[/E2] (PKC), by the tyrosine kinase inhibitor genistein and by MAPK kinase (MEK) inhibitor, PD98059", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "AVP", "entity_1_idx": [[38, 41]], "entity_1_idx_in_text_with_entity_marker": [42, 45], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase C", "entity_2_idx": [[84, 100]], "entity_2_idx_in_text_with_entity_marker": [97, 113], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d62.s159_IEPA.d62.s159.p0", "text": "Oxytocin-treated male rats had increased circulating levels of cholecystokinin, a tendency to increased plasma levels of insulin (p = 0.066), and relatively more adipose tissue in the thigh and interscapular region, compared with controls", "text_with_entity_marker": "[E1]Oxytocin[/E1]-treated male rats had increased circulating levels of cholecystokinin, a tendency to increased plasma levels of [E2]insulin[/E2] (p = 0.066), and relatively more adipose tissue in the thigh and interscapular region, compared with controls", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Oxytocin", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[121, 128]], "entity_2_idx_in_text_with_entity_marker": [134, 141], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d65.s165_IEPA.d65.s165.p0", "text": "These results argue that Ca(2+)-dependent PKC is involved in the action of AVP, and that of other agonists, which stimulate sodium transport", "text_with_entity_marker": "These results argue that Ca(2+)-dependent [E1]PKC[/E1] is involved in the action of [E2]AVP[/E2], and that of other agonists, which stimulate sodium transport", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PKC", "entity_1_idx": [[42, 45]], "entity_1_idx_in_text_with_entity_marker": [46, 49], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[75, 78]], "entity_2_idx_in_text_with_entity_marker": [88, 91], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d66.s166_IEPA.d66.s166.p0", "text": "However, the AVP-dependent stimulation required activation of protein kinase C (PKC), whereas the inhibition was PKC independent, indicating that the NGF-induced signaling pathways leading to inhibition and stimulation of HCO3- absorption are distinct", "text_with_entity_marker": "However, the [E1]AVP[/E1]-dependent stimulation required activation of [E2]protein kinase C[/E2] (PKC), whereas the inhibition was PKC independent, indicating that the NGF-induced signaling pathways leading to inhibition and stimulation of HCO3- absorption are distinct", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "AVP", "entity_1_idx": [[13, 16]], "entity_1_idx_in_text_with_entity_marker": [17, 20], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase C", "entity_2_idx": [[62, 78]], "entity_2_idx_in_text_with_entity_marker": [75, 91], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d67.s167_IEPA.d67.s167.p0", "text": "Association of the insulin receptor with phospholipase C-gamma (PLCgamma) in 3T3-L1 adipocytes suggests a role for PLCgamma in metabolic signaling by insulin", "text_with_entity_marker": "Association of the insulin receptor with [E1]phospholipase C-gamma[/E1] (PLCgamma) in 3T3-L1 adipocytes suggests a role for [E2]PLCgamma[/E2] in metabolic signaling by insulin", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phospholipase C-gamma", "entity_1_idx": [[41, 62]], "entity_1_idx_in_text_with_entity_marker": [45, 66], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLCgamma", "entity_2_idx": [[115, 123]], "entity_2_idx_in_text_with_entity_marker": [128, 136], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d74.s176_IEPA.d74.s176.p0", "text": "Chronic central leptin infusion enhances insulin-stimulated glucose metabolism and favors the expression of uncoupling proteins", "text_with_entity_marker": "Chronic central [E1]leptin[/E1] infusion enhances insulin-stimulated glucose metabolism and favors the expression of [E2]uncoupling proteins[/E2]", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[16, 22]], "entity_1_idx_in_text_with_entity_marker": [20, 26], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling proteins", "entity_2_idx": [[108, 127]], "entity_2_idx_in_text_with_entity_marker": [121, 140], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d74.s178_IEPA.d74.s178.p4", "text": "While leptin maintains or favors energy-dissipating mechanisms (UCP1, UCP2, and UCP3), the latter are markedly depressed in pair-fed rats", "text_with_entity_marker": "While leptin maintains or favors energy-dissipating mechanisms ([E1]UCP1[/E1], UCP2, and [E2]UCP3[/E2]), the latter are markedly depressed in pair-fed rats", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP1", "entity_1_idx": [[64, 68]], "entity_1_idx_in_text_with_entity_marker": [68, 72], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[80, 84]], "entity_2_idx_in_text_with_entity_marker": [93, 97], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d76.s184_IEPA.d76.s184.p0", "text": "In contrast, the oxytocin response to insulin-induced hypoglycemia was significantly reduced by melatonin treatment", "text_with_entity_marker": "In contrast, the [E1]oxytocin[/E1] response to [E2]insulin[/E2]-induced hypoglycemia was significantly reduced by melatonin treatment", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[17, 25]], "entity_1_idx_in_text_with_entity_marker": [21, 29], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[38, 45]], "entity_2_idx_in_text_with_entity_marker": [51, 58], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d78.s188_IEPA.d78.s188.p1", "text": "These results confirm that AVP and PMA activate PKC and indicate that IL-1 likely does not activate PKC in Leydig cells", "text_with_entity_marker": "These results confirm that [E1]AVP[/E1] and PMA activate PKC and indicate that IL-1 likely does not activate [E2]PKC[/E2] in Leydig cells", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AVP", "entity_1_idx": [[27, 30]], "entity_1_idx_in_text_with_entity_marker": [31, 34], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PKC", "entity_2_idx": [[100, 103]], "entity_2_idx_in_text_with_entity_marker": [113, 116], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d80.s190_IEPA.d80.s190.p1", "text": "To explore the possible roles of the hypothalamic melanocortin system in leptin action, we examined the effects of intracerebroventricular (i.c.v.) injection of leptin with or without SHU9119, a potent antagonist of alpha-melanocyte stimulating hormone, on food intake, body weight, and mitochondrial uncoupling protein-1 (UCP-1) mRNA expression in the brown adipose tissue (BAT) in rats", "text_with_entity_marker": "To explore the possible roles of the hypothalamic melanocortin system in [E1]leptin[/E1] action, we examined the effects of intracerebroventricular (i.c.v.) injection of leptin with or without SHU9119, a potent antagonist of alpha-melanocyte stimulating hormone, on food intake, body weight, and mitochondrial [E2]uncoupling protein-1[/E2] (UCP-1) mRNA expression in the brown adipose tissue (BAT) in rats", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[73, 79]], "entity_1_idx_in_text_with_entity_marker": [77, 83], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling protein-1", "entity_2_idx": [[301, 321]], "entity_2_idx_in_text_with_entity_marker": [314, 334], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d82.s196_IEPA.d82.s196.p0", "text": "NPY in the PVN increases feeding and decreases uncoupling protein (UCP) activity in brown fat, whereas leptin decreases NPY biosynthesis in the Arc, which presumably decreases PVN NPY", "text_with_entity_marker": "NPY in the PVN increases feeding and decreases [E1]uncoupling protein[/E1] (UCP) activity in brown fat, whereas [E2]leptin[/E2] decreases NPY biosynthesis in the Arc, which presumably decreases PVN NPY", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "uncoupling protein", "entity_1_idx": [[47, 65]], "entity_1_idx_in_text_with_entity_marker": [51, 69], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[103, 109]], "entity_2_idx_in_text_with_entity_marker": [116, 122], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d84.s199_IEPA.d84.s199.p2", "text": "Effect of residual endogenous insulin secretion on the abnormal oxytocin response to hypoglycaemia in insulin-dependent diabetics", "text_with_entity_marker": "Effect of residual endogenous insulin secretion on the abnormal [E1]oxytocin[/E1] response to hypoglycaemia in [E2]insulin[/E2]-dependent diabetics", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "oxytocin", "entity_1_idx": [[64, 72]], "entity_1_idx_in_text_with_entity_marker": [68, 76], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[102, 109]], "entity_2_idx_in_text_with_entity_marker": [115, 122], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d88.s207_IEPA.d88.s207.p1", "text": "To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "text_with_entity_marker": "To elucidate the pathophysiologic significance of [E1]UCP3[/E1] and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with [E2]leptin[/E2] receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP3", "entity_1_idx": [[50, 54]], "entity_1_idx_in_text_with_entity_marker": [54, 58], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[290, 296]], "entity_2_idx_in_text_with_entity_marker": [303, 309], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d88.s208_IEPA.d88.s208.p1", "text": "These results clearly demonstrate that UCP3 gene expression is upregulated by TZDs in the WAT and BAT in Wistar fatty rats, an obese model with leptin receptor defect, and that adipose UCP3 gene expression is increased in response to TZDs in vitro", "text_with_entity_marker": "These results clearly demonstrate that [E1]UCP3[/E1] gene expression is upregulated by TZDs in the WAT and BAT in Wistar fatty rats, an obese model with leptin receptor defect, and that adipose [E2]UCP3[/E2] gene expression is increased in response to TZDs in vitro", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP3", "entity_1_idx": [[39, 43]], "entity_1_idx_in_text_with_entity_marker": [43, 47], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[185, 189]], "entity_2_idx_in_text_with_entity_marker": [198, 202], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d89.s209_IEPA.d89.s209.p3", "text": "UCP2, UCP3 and leptin gene expression: modulation by food restriction and leptin", "text_with_entity_marker": "UCP2, [E1]UCP3[/E1] and [E2]leptin[/E2] gene expression: modulation by food restriction and leptin", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP3", "entity_1_idx": [[6, 10]], "entity_1_idx_in_text_with_entity_marker": [10, 14], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[15, 21]], "entity_2_idx_in_text_with_entity_marker": [28, 34], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d89.s211_IEPA.d89.s211.p0", "text": "Leptin increased LPL mRNA by 80%, UCP1 mRNA twofold, and UCP3 mRNA levels by 62% in BAT, and increased UCP2 mRNA levels twofold in EWAT", "text_with_entity_marker": "[E1]Leptin[/E1] increased LPL mRNA by 80%, [E2]UCP1[/E2] mRNA twofold, and UCP3 mRNA levels by 62% in BAT, and increased UCP2 mRNA levels twofold in EWAT", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP1", "entity_2_idx": [[34, 38]], "entity_2_idx_in_text_with_entity_marker": [47, 51], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d89.s212_IEPA.d89.s212.p0", "text": "The present study indicates that leptin increases the gene expression of UCP2 in EWAT and that of UCP1, UCP3 and LPL in BAT, whereas reduced food consumption but not leptin, decreases LPL expression in WAT", "text_with_entity_marker": "The present study indicates that [E1]leptin[/E1] increases the gene expression of [E2]UCP2[/E2] in EWAT and that of UCP1, UCP3 and LPL in BAT, whereas reduced food consumption but not leptin, decreases LPL expression in WAT", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[33, 39]], "entity_1_idx_in_text_with_entity_marker": [37, 43], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP2", "entity_2_idx": [[73, 77]], "entity_2_idx_in_text_with_entity_marker": [86, 90], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d91.s215_IEPA.d91.s215.p0", "text": "Oxytocin-stimulated insulin release in a clonal beta-cell line RINm5F: involvement of phospholipase C-dependent and -independent pathways.", "text_with_entity_marker": "Oxytocin-stimulated [E1]insulin[/E1] release in a clonal beta-cell line RINm5F: involvement of [E2]phospholipase C[/E2]-dependent and -independent pathways.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[20, 27]], "entity_1_idx_in_text_with_entity_marker": [24, 31], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[86, 101]], "entity_2_idx_in_text_with_entity_marker": [99, 114], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d91.s216_IEPA.d91.s216.p0", "text": "CONCLUSION: Oxy increases insulin release through both PLC and non-PLC mediated signal transduction mechanisms.", "text_with_entity_marker": "CONCLUSION: Oxy increases [E1]insulin[/E1] release through both [E2]PLC[/E2] and non-PLC mediated signal transduction mechanisms.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[26, 33]], "entity_1_idx_in_text_with_entity_marker": [30, 37], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLC", "entity_2_idx": [[55, 58]], "entity_2_idx_in_text_with_entity_marker": [68, 71], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d91.s222_IEPA.d91.s222.p0", "text": "Oxy-induced insulin release was not altered by pretreatment with pertussis toxin (PT)", "text_with_entity_marker": "[E1]Oxy[/E1]-induced [E2]insulin[/E2] release was not altered by pretreatment with pertussis toxin (PT)", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Oxy", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[12, 19]], "entity_2_idx_in_text_with_entity_marker": [25, 32], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d95.s230_IEPA.d95.s230.p0", "text": "Species differences in the location of the Ca2+-dependent PKC isoforms suggest differences in function such as the relaying of photic or non-photic information to the clock mechanism, or the synchronization of AVP neurons and their subsequent output signals", "text_with_entity_marker": "Species differences in the location of the Ca2+-dependent [E1]PKC[/E1] isoforms suggest differences in function such as the relaying of photic or non-photic information to the clock mechanism, or the synchronization of [E2]AVP[/E2] neurons and their subsequent output signals", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PKC", "entity_1_idx": [[58, 61]], "entity_1_idx_in_text_with_entity_marker": [62, 65], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[210, 213]], "entity_2_idx_in_text_with_entity_marker": [223, 226], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d98.s236_IEPA.d98.s236.p0", "text": "We observed that primary microglial cultures and the THP-1 monocytic cell line are stimulated by fibrillar beta-amyloid and prion peptides to activate identical tyrosine kinase-dependent inflammatory signal transduction cascades", "text_with_entity_marker": "We observed that primary microglial cultures and the THP-1 monocytic cell line are stimulated by fibrillar beta-amyloid and [E1]prion[/E1] peptides to activate identical [E2]tyrosine kinase[/E2]-dependent inflammatory signal transduction cascades", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "prion", "entity_1_idx": [[124, 129]], "entity_1_idx_in_text_with_entity_marker": [128, 133], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "tyrosine kinase", "entity_2_idx": [[161, 176]], "entity_2_idx_in_text_with_entity_marker": [174, 189], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d102.s241_IEPA.d102.s241.p0", "text": "Constitutive expression of PKABA1 drastically suppressed expression of low- and high-pI alpha-amylase and protease genes induced by GA", "text_with_entity_marker": "Constitutive expression of PKABA1 drastically suppressed expression of low- and high-pI [E1]alpha-amylase[/E1] and protease genes induced by [E2]GA[/E2]", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-amylase", "entity_1_idx": [[88, 101]], "entity_1_idx_in_text_with_entity_marker": [92, 105], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "GA", "entity_2_idx": [[132, 134]], "entity_2_idx_in_text_with_entity_marker": [145, 147], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d106.s245_IEPA.d106.s245.p2", "text": "Protein kinase C (PKC) inhibitors reversed AVP inhibition, whereas PKC activator inhibited nitrite production", "text_with_entity_marker": "Protein kinase C (PKC) inhibitors reversed [E1]AVP[/E1] inhibition, whereas [E2]PKC[/E2] activator inhibited nitrite production", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AVP", "entity_1_idx": [[43, 46]], "entity_1_idx_in_text_with_entity_marker": [47, 50], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PKC", "entity_2_idx": [[67, 70]], "entity_2_idx_in_text_with_entity_marker": [80, 83], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d108.s252_IEPA.d108.s252.p2", "text": "The present study was designed to investigate how repeated injections of oxytocin influence plasma levels of vagally controlled hormones such as gastrin, cholecystokinin (CCK), insulin and somatostatin, as well as of endogenous oxytocin and glucose", "text_with_entity_marker": "The present study was designed to investigate how repeated injections of oxytocin influence plasma levels of vagally controlled hormones such as gastrin, cholecystokinin (CCK), [E1]insulin[/E1] and somatostatin, as well as of endogenous [E2]oxytocin[/E2] and glucose", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[177, 184]], "entity_1_idx_in_text_with_entity_marker": [181, 188], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[228, 236]], "entity_2_idx_in_text_with_entity_marker": [241, 249], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d108.s254_IEPA.d108.s254.p1", "text": "When the alpha2-adrenoreceptor agonist clonidine (2.5 microgram/kg intracerebroventricularly) was administered 3 days after the 5-day treatment period with oxytocin or saline, plasma levels of insulin and CCK increased significantly (p < 0.05) in the oxytocin-treated rats, when compared to saline-treated controls receiving clonidine only", "text_with_entity_marker": "When the alpha2-adrenoreceptor agonist clonidine (2.5 microgram/kg intracerebroventricularly) was administered 3 days after the 5-day treatment period with [E1]oxytocin[/E1] or saline, plasma levels of insulin and CCK increased significantly (p < 0.05) in the [E2]oxytocin[/E2]-treated rats, when compared to saline-treated controls receiving clonidine only", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "oxytocin", "entity_1_idx": [[156, 164]], "entity_1_idx_in_text_with_entity_marker": [160, 168], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[251, 259]], "entity_2_idx_in_text_with_entity_marker": [264, 272], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d114.s274_IEPA.d114.s274.p1", "text": "In normal pancreatic islets, UCP-2 is upregulated by leptin and is low in leptin-resistant islets of ZDF rats", "text_with_entity_marker": "In normal pancreatic islets, [E1]UCP-2[/E1] is upregulated by leptin and is low in [E2]leptin[/E2]-resistant islets of ZDF rats", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP-2", "entity_1_idx": [[29, 34]], "entity_1_idx_in_text_with_entity_marker": [33, 38], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[74, 80]], "entity_2_idx_in_text_with_entity_marker": [87, 93], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d114.s276_IEPA.d114.s276.p0", "text": "We conclude that UCP-2 has uncoupling function when overexpressed in leptin-insensitive islets and that its overexpression corrects the underexpression of the insulin gene and ameliorates glucose-stimulated insulin secretion, possibly by increasing the ATP:ADP ratio", "text_with_entity_marker": "We conclude that [E1]UCP-2[/E1] has uncoupling function when overexpressed in [E2]leptin[/E2]-insensitive islets and that its overexpression corrects the underexpression of the insulin gene and ameliorates glucose-stimulated insulin secretion, possibly by increasing the ATP:ADP ratio", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP-2", "entity_1_idx": [[17, 22]], "entity_1_idx_in_text_with_entity_marker": [21, 26], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[69, 75]], "entity_2_idx_in_text_with_entity_marker": [82, 88], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d116.s284_IEPA.d116.s284.p1", "text": "In the present study we found that at increasing GA concentrations, increasing numbers of barley (Hordeum vulgare) cells showed the enhanced amylase secretion and vacuolation characteristic of the GA response", "text_with_entity_marker": "In the present study we found that at increasing [E1]GA[/E1] concentrations, increasing numbers of barley (Hordeum vulgare) cells showed the enhanced amylase secretion and vacuolation characteristic of the [E2]GA[/E2] response", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "GA", "entity_1_idx": [[49, 51]], "entity_1_idx_in_text_with_entity_marker": [53, 55], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "GA", "entity_2_idx": [[197, 199]], "entity_2_idx_in_text_with_entity_marker": [210, 212], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d118.s286_IEPA.d118.s286.p0", "text": "Phorbol myristate acetate (TPA), an activator of PKC, elicited an increase of MAPK activity, but did not further influence the level of AVP4-8-enhanced MAPK activity; Nevertheless, the extent of CaMKII activation was attenuated by TPA", "text_with_entity_marker": "Phorbol myristate acetate (TPA), an activator of [E1]PKC[/E1], elicited an increase of MAPK activity, but did not further influence the level of [E2]AVP[/E2]4-8-enhanced MAPK activity; Nevertheless, the extent of CaMKII activation was attenuated by TPA", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PKC", "entity_1_idx": [[49, 52]], "entity_1_idx_in_text_with_entity_marker": [53, 56], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[136, 139]], "entity_2_idx_in_text_with_entity_marker": [149, 152], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d122.s293_IEPA.d122.s293.p0", "text": "I.v. leptin infusion also favored the expression of UCPs in brown adipose tissue, either by increasing their expression or preventing the fall occurring during the pair-feeding regimen.", "text_with_entity_marker": "I.v. [E1]leptin[/E1] infusion also favored the expression of [E2]UCPs[/E2] in brown adipose tissue, either by increasing their expression or preventing the fall occurring during the pair-feeding regimen.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[5, 11]], "entity_1_idx_in_text_with_entity_marker": [9, 15], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCPs", "entity_2_idx": [[52, 56]], "entity_2_idx_in_text_with_entity_marker": [65, 69], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d122.s294_IEPA.d122.s294.p1", "text": "Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively", "text_with_entity_marker": "Relative [E1]UCP[/E1] expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for [E2]UCP2[/E2] and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP", "entity_1_idx": [[9, 12]], "entity_1_idx_in_text_with_entity_marker": [13, 16], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP2", "entity_2_idx": [[85, 89]], "entity_2_idx_in_text_with_entity_marker": [98, 102], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d127.s301_IEPA.d127.s301.p0", "text": "PI-PLC treatment of fetal guinea pig brain cultures substantially reduced the amount of Abeta40 and Abeta42 in the medium but had no effect on sAPPalpha", "text_with_entity_marker": "[E1]PI-PLC[/E1] treatment of fetal guinea pig brain cultures substantially reduced the amount of [E2]Abeta40[/E2] and Abeta42 in the medium but had no effect on sAPPalpha", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PI-PLC", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "Abeta40", "entity_2_idx": [[88, 95]], "entity_2_idx_in_text_with_entity_marker": [101, 108], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d127.s302_IEPA.d127.s302.p4", "text": "When this parental line was treated with PI-PLC, Abeta40, Abeta42, and sAPPbeta decreased to levels similar to those observed in the mutant line, and the mutant line was resistant to these effects of PI-PLC", "text_with_entity_marker": "When this parental line was treated with PI-PLC, [E1]Abeta40[/E1], Abeta42, and sAPPbeta decreased to levels similar to those observed in the mutant line, and the mutant line was resistant to these effects of [E2]PI-PLC[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Abeta40", "entity_1_idx": [[49, 56]], "entity_1_idx_in_text_with_entity_marker": [53, 60], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PI-PLC", "entity_2_idx": [[200, 206]], "entity_2_idx_in_text_with_entity_marker": [213, 219], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d128.s304_IEPA.d128.s304.p0", "text": "In its non-aggregated form, Abeta 25-35 activates PI-PLC but in the aggregated form the enzymatic activity decreased", "text_with_entity_marker": "In its non-aggregated form, [E1]Abeta 25-35[/E1] activates [E2]PI-PLC[/E2] but in the aggregated form the enzymatic activity decreased", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Abeta 25-35", "entity_1_idx": [[28, 39]], "entity_1_idx_in_text_with_entity_marker": [32, 43], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PI-PLC", "entity_2_idx": [[50, 56]], "entity_2_idx_in_text_with_entity_marker": [63, 69], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d129.s308_IEPA.d129.s308.p0", "text": "To further investigate neural effects on leptin and uncoupling proteins (UCPs), we studied in vivo perturbations intended to block adrenergic input to peripheral tissues", "text_with_entity_marker": "To further investigate neural effects on [E1]leptin[/E1] and [E2]uncoupling proteins[/E2] (UCPs), we studied in vivo perturbations intended to block adrenergic input to peripheral tissues", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[41, 47]], "entity_1_idx_in_text_with_entity_marker": [45, 51], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling proteins", "entity_2_idx": [[52, 71]], "entity_2_idx_in_text_with_entity_marker": [65, 84], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d130.s313_IEPA.d130.s313.p0", "text": "Fresh-water-soluble A beta 25-35 activated PI-PLC in SPM markedly by two- to threefold, but this effect was absent in the presence of 2 mM CaCl2", "text_with_entity_marker": "Fresh-water-soluble [E1]A beta[/E1] 25-35 activated [E2]PI-PLC[/E2] in SPM markedly by two- to threefold, but this effect was absent in the presence of 2 mM CaCl2", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "A beta", "entity_1_idx": [[20, 26]], "entity_1_idx_in_text_with_entity_marker": [24, 30], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PI-PLC", "entity_2_idx": [[43, 49]], "entity_2_idx_in_text_with_entity_marker": [56, 62], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d130.s314_IEPA.d130.s314.p5", "text": "Moreover, A beta 25-35 had no effect on basal PIP2-PLC activity and cytosolic PI-PLC and PIP2-PLC", "text_with_entity_marker": "Moreover, A beta 25-35 had no effect on basal PIP2-PLC activity and cytosolic [E1]PI-PLC[/E1] and [E2]PIP2-PLC[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PI-PLC", "entity_1_idx": [[78, 84]], "entity_1_idx_in_text_with_entity_marker": [82, 88], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PIP2-PLC", "entity_2_idx": [[89, 97]], "entity_2_idx_in_text_with_entity_marker": [102, 110], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d138.s328_IEPA.d138.s328.p2", "text": "In addition, glycosyl-phosphatidylinositol-specific phospholipase C (GPI-PLC), which in isolated rat adipocytes is activated by insulin, was stimulated to up to 5-fold by glucose and 10-fold by glucose plus insulin in both yeast spheroplasts and intact cells leading to a concentration-dependent leftward shift of the glucose-response curve for activation of the GPI-PLC", "text_with_entity_marker": "In addition, [E1]glycosyl-phosphatidylinositol-specific phospholipase C[/E1] (GPI-PLC), which in isolated rat adipocytes is activated by insulin, was stimulated to up to 5-fold by glucose and 10-fold by glucose plus insulin in both yeast spheroplasts and intact cells leading to a concentration-dependent leftward shift of the glucose-response curve for activation of the [E2]GPI-PLC[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "glycosyl-phosphatidylinositol-specific phospholipase C", "entity_1_idx": [[13, 67]], "entity_1_idx_in_text_with_entity_marker": [17, 71], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "GPI-PLC", "entity_2_idx": [[363, 370]], "entity_2_idx_in_text_with_entity_marker": [376, 383], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d138.s330_IEPA.d138.s330.p0", "text": "As the GPI-PLC reaction is rate limiting, the efficiency of the two-step anchor cleavage was significantly increased when insulin was present together with glucose as compared to glucose alone", "text_with_entity_marker": "As the [E1]GPI-PLC[/E1] reaction is rate limiting, the efficiency of the two-step anchor cleavage was significantly increased when [E2]insulin[/E2] was present together with glucose as compared to glucose alone", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "GPI-PLC", "entity_1_idx": [[7, 14]], "entity_1_idx_in_text_with_entity_marker": [11, 18], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[122, 129]], "entity_2_idx_in_text_with_entity_marker": [135, 142], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d138.s331_IEPA.d138.s331.p0", "text": "The insulin concentrations effective in modulating PP2A, PKA, cAMP-PDE, and GPI-PLC activities correlate well with those required for half-saturation of the specific binding sites as well as for stimulation of protein phosphorylation and glycogen accumulation", "text_with_entity_marker": "The [E1]insulin[/E1] concentrations effective in modulating PP2A, PKA, cAMP-PDE, and [E2]GPI-PLC[/E2] activities correlate well with those required for half-saturation of the specific binding sites as well as for stimulation of protein phosphorylation and glycogen accumulation", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[4, 11]], "entity_1_idx_in_text_with_entity_marker": [8, 15], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "GPI-PLC", "entity_2_idx": [[76, 83]], "entity_2_idx_in_text_with_entity_marker": [89, 96], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d140.s336_IEPA.d140.s336.p0", "text": "However, AVP-induced activation of RSK2, a downstream substrate of ERK1 and ERK2, was PKC-dependent and PI 3-kinase-independent", "text_with_entity_marker": "However, [E1]AVP[/E1]-induced activation of RSK2, a downstream substrate of ERK1 and ERK2, was [E2]PKC[/E2]-dependent and PI 3-kinase-independent", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "AVP", "entity_1_idx": [[9, 12]], "entity_1_idx_in_text_with_entity_marker": [13, 16], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PKC", "entity_2_idx": [[86, 89]], "entity_2_idx_in_text_with_entity_marker": [99, 102], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d141.s339_IEPA.d141.s339.p1", "text": "We examined whether tolbutamide and diazoxide, which close or open ATP-sensitive K(+) channels (K(ATP) channels), respectively, interact with PLC-linked Ca(2+) signals in HIT-T15 and mouse beta-cells and with PLC-linked insulin secretion from HIT-T15 cells", "text_with_entity_marker": "We examined whether tolbutamide and diazoxide, which close or open ATP-sensitive K(+) channels (K(ATP) channels), respectively, interact with [E1]PLC[/E1]-linked Ca(2+) signals in HIT-T15 and mouse beta-cells and with PLC-linked [E2]insulin[/E2] secretion from HIT-T15 cells", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PLC", "entity_1_idx": [[142, 145]], "entity_1_idx_in_text_with_entity_marker": [146, 149], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[220, 227]], "entity_2_idx_in_text_with_entity_marker": [233, 240], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d142.s342_IEPA.d142.s342.p0", "text": "Furthermore, no association was found between the Gln27Glu or the Gly16Arg polymorphisms and plasma leptin or adipose tissue UCP-1 gene expression in either group", "text_with_entity_marker": "Furthermore, no association was found between the Gln27Glu or the Gly16Arg polymorphisms and plasma [E1]leptin[/E1] or adipose tissue [E2]UCP-1[/E2] gene expression in either group", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[100, 106]], "entity_1_idx_in_text_with_entity_marker": [104, 110], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-1", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d147.s357_IEPA.d147.s357.p0", "text": "Ten protein kinases have been assayed for their ability to phosphorylate in vitro the recombinant bovine PrP (25-242) (rbPrP)", "text_with_entity_marker": "Ten [E1]protein kinases[/E1] have been assayed for their ability to phosphorylate in vitro the [E2]recombinant bovine PrP[/E2] (25-242) (rbPrP)", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "protein kinases", "entity_1_idx": [[4, 19]], "entity_1_idx_in_text_with_entity_marker": [8, 23], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "recombinant bovine PrP", "entity_2_idx": [[86, 108]], "entity_2_idx_in_text_with_entity_marker": [99, 121], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d148.s360_IEPA.d148.s360.p0", "text": "OBJECTIVE: To assess the effect of chronic treatment with CGP-12177 a beta3-adrenergic receptor (AR) agonist with beta2/beta1-AR antagonist action, on the expression of the leptin gene and of genes coding for uncoupling proteins (ucp1, ucp2 and ucp3) in brown and white adipose tissues", "text_with_entity_marker": "OBJECTIVE: To assess the effect of chronic treatment with CGP-12177 a beta3-adrenergic receptor (AR) agonist with beta2/beta1-AR antagonist action, on the expression of the [E1]leptin[/E1] gene and of genes coding for [E2]uncoupling proteins[/E2] (ucp1, ucp2 and ucp3) in brown and white adipose tissues", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[173, 179]], "entity_1_idx_in_text_with_entity_marker": [177, 183], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling proteins", "entity_2_idx": [[209, 228]], "entity_2_idx_in_text_with_entity_marker": [222, 241], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d151.s366_IEPA.d151.s366.p0", "text": "OBJECTIVE: To determine whether hormonal status may affect neuropeptide Y (NPY), galanin, and leptin release in postmenopausal women and in young women", "text_with_entity_marker": "OBJECTIVE: To determine whether hormonal status may affect [E1]neuropeptide Y[/E1] (NPY), galanin, and [E2]leptin[/E2] release in postmenopausal women and in young women", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "neuropeptide Y", "entity_1_idx": [[59, 73]], "entity_1_idx_in_text_with_entity_marker": [63, 77], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[94, 100]], "entity_2_idx_in_text_with_entity_marker": [107, 113], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d161.s389_IEPA.d161.s389.p0", "text": "These data suggest that the in vivo gene expression of FAT/CD36, PPAR-gamma2, leptin, UCP-2, UCP-3, and TNF-alpha in subcutaneous adipose tissue is regulated by circulating lipids independent of insulin and that prolonged hyperlipidemia may therefore contribute to increased fat metabolism and storage as a result of the increased expression of these proteins", "text_with_entity_marker": "These data suggest that the in vivo gene expression of FAT/CD36, PPAR-gamma2, [E1]leptin[/E1], [E2]UCP-2[/E2], UCP-3, and TNF-alpha in subcutaneous adipose tissue is regulated by circulating lipids independent of insulin and that prolonged hyperlipidemia may therefore contribute to increased fat metabolism and storage as a result of the increased expression of these proteins", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[78, 84]], "entity_1_idx_in_text_with_entity_marker": [82, 88], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-2", "entity_2_idx": [[86, 91]], "entity_2_idx_in_text_with_entity_marker": [99, 104], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d168.s408_IEPA.d168.s408.p2", "text": "These results suggest that central leptin stimulates T3 production via an activation of T4 to T3 conversion, and that this stimulation could be responsible for the effect of leptin on muscle UCP-3 expression", "text_with_entity_marker": "These results suggest that central leptin stimulates T3 production via an activation of T4 to T3 conversion, and that this stimulation could be responsible for the effect of [E1]leptin[/E1] on muscle [E2]UCP-3[/E2] expression", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[174, 180]], "entity_1_idx_in_text_with_entity_marker": [178, 184], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[191, 196]], "entity_2_idx_in_text_with_entity_marker": [204, 209], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d170.s411_IEPA.d170.s411.p0", "text": "Obesity occurs in 60% of women after menopause and is characterized by an excess of adipose tissue that depends on several orexigenic (neuropeptide Y (NPY) stimulates carbohydrate ingestion, galanin stimulates fat intake) and anorectic (leptin, cholecystokinin (CCK)) factors", "text_with_entity_marker": "Obesity occurs in 60% of women after menopause and is characterized by an excess of adipose tissue that depends on several orexigenic ([E1]neuropeptide Y[/E1] (NPY) stimulates carbohydrate ingestion, galanin stimulates fat intake) and anorectic ([E2]leptin[/E2], cholecystokinin (CCK)) factors", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "neuropeptide Y", "entity_1_idx": [[135, 149]], "entity_1_idx_in_text_with_entity_marker": [139, 153], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[237, 243]], "entity_2_idx_in_text_with_entity_marker": [250, 256], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d173.s421_IEPA.d173.s421.p2", "text": "Overall, our data indicate that the normal processing of PrP(c) is up-regulated by protein kinase C but not protein kinase A in human cells and murine neurons", "text_with_entity_marker": "Overall, our data indicate that the normal processing of PrP(c) is up-regulated by [E1]protein kinase C[/E1] but not [E2]protein kinase A[/E2] in human cells and murine neurons", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "protein kinase C", "entity_1_idx": [[83, 99]], "entity_1_idx_in_text_with_entity_marker": [87, 103], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase A", "entity_2_idx": [[108, 124]], "entity_2_idx_in_text_with_entity_marker": [121, 137], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d174.s422_IEPA.d174.s422.p0", "text": "Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration", "text_with_entity_marker": "Dietary intakes of [E1]flavonols[/E1], [E2]flavones[/E2] and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "flavonols", "entity_1_idx": [[19, 28]], "entity_1_idx_in_text_with_entity_marker": [23, 32], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "flavones", "entity_2_idx": [[30, 38]], "entity_2_idx_in_text_with_entity_marker": [43, 51], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d174.s422_IEPA.d174.s422.p5", "text": "Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration", "text_with_entity_marker": "Dietary intakes of flavonols, flavones and [E1]isoflavones[/E1] by Japanese women and the inverse correlation between quercetin intake and plasma LDL [E2]cholesterol[/E2] concentration", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "isoflavones", "entity_1_idx": [[43, 54]], "entity_1_idx_in_text_with_entity_marker": [47, 58], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "cholesterol", "entity_2_idx": [[141, 152]], "entity_2_idx_in_text_with_entity_marker": [154, 165], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d175.s424_IEPA.d175.s424.p0", "text": "Although the above data are consistent with a direct ability of leptin to promote TRH biosynthesis through actions on TRH neurons, addition of a-MSH produced a 3.5 fold increase in TRH biosynthesis and release, whereas NPY treatment suppressed ~3 fold proTRH biosynthesis", "text_with_entity_marker": "Although the above data are consistent with a direct ability of [E1]leptin[/E1] to promote TRH biosynthesis through actions on TRH neurons, addition of a-MSH produced a 3.5 fold increase in TRH biosynthesis and release, whereas [E2]NPY[/E2] treatment suppressed ~3 fold proTRH biosynthesis", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[64, 70]], "entity_1_idx_in_text_with_entity_marker": [68, 74], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[219, 222]], "entity_2_idx_in_text_with_entity_marker": [232, 235], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d177.s426_IEPA.d177.s426.p0", "text": "As expected, in fusion of NPY alone (18 microg/day) augmented food intake (191.6% over the initial control, P < 0.05) and produced a 25.1% weight gain in conjunction with a 10-fold increase in serum leptin concentrations at the end of the 7-day period", "text_with_entity_marker": "As expected, in fusion of [E1]NPY[/E1] alone (18 microg/day) augmented food intake (191.6% over the initial control, P < 0.05) and produced a 25.1% weight gain in conjunction with a 10-fold increase in serum [E2]leptin[/E2] concentrations at the end of the 7-day period", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "NPY", "entity_1_idx": [[26, 29]], "entity_1_idx_in_text_with_entity_marker": [30, 33], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[199, 205]], "entity_2_idx_in_text_with_entity_marker": [212, 218], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d177.s427_IEPA.d177.s427.p0", "text": "Interestingly, coinfusion of this regimen of NPY with the highly effective anorectic and body reducing effects of CNTF (5.0 microg/day) not only prevented the CNTF-induced anorexia and weight loss, but also normalized serum leptin concentrations and hypothalamic NPY gene expression", "text_with_entity_marker": "Interestingly, coinfusion of this regimen of [E1]NPY[/E1] with the highly effective anorectic and body reducing effects of CNTF (5.0 microg/day) not only prevented the CNTF-induced anorexia and weight loss, but also normalized serum [E2]leptin[/E2] concentrations and hypothalamic NPY gene expression", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "NPY", "entity_1_idx": [[45, 48]], "entity_1_idx_in_text_with_entity_marker": [49, 52], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[224, 230]], "entity_2_idx_in_text_with_entity_marker": [237, 243], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d184.s441_IEPA.d184.s441.p0", "text": "These results suggest that T3 may increase UCP family expression independent of leptin action", "text_with_entity_marker": "These results suggest that T3 may increase [E1]UCP[/E1] family expression independent of [E2]leptin[/E2] action", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP", "entity_1_idx": [[43, 46]], "entity_1_idx_in_text_with_entity_marker": [47, 50], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[80, 86]], "entity_2_idx_in_text_with_entity_marker": [93, 99], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d185.s443_IEPA.d185.s443.p2", "text": "ARC NPY neurones also mediate hyperphagia and obesity in the ob/ob and db/db mice and fa/fa rat, in which leptin inhibition is lost through mutations affecting leptin or its receptor", "text_with_entity_marker": "ARC NPY neurones also mediate hyperphagia and obesity in the ob/ob and db/db mice and fa/fa rat, in which [E1]leptin[/E1] inhibition is lost through mutations affecting [E2]leptin[/E2] or its receptor", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[106, 112]], "entity_1_idx_in_text_with_entity_marker": [110, 116], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[160, 166]], "entity_2_idx_in_text_with_entity_marker": [173, 179], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d188.s452_IEPA.d188.s452.p0", "text": "In contrast, leptin decreased body weight and adiposity, increased CART and suppressed NPY and AGRP mRNA expression in adult mice", "text_with_entity_marker": "In contrast, [E1]leptin[/E1] decreased body weight and adiposity, increased CART and suppressed [E2]NPY[/E2] and AGRP mRNA expression in adult mice", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[13, 19]], "entity_1_idx_in_text_with_entity_marker": [17, 23], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[87, 90]], "entity_2_idx_in_text_with_entity_marker": [100, 103], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d190.s458_IEPA.d190.s458.p0", "text": "In conclusion, leptin and NPY show separate permissive effects on GnRH secretion in the adult rat hypothalamus.", "text_with_entity_marker": "In conclusion, [E1]leptin[/E1] and [E2]NPY[/E2] show separate permissive effects on GnRH secretion in the adult rat hypothalamus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[15, 21]], "entity_1_idx_in_text_with_entity_marker": [19, 25], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[26, 29]], "entity_2_idx_in_text_with_entity_marker": [39, 42], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d194.s467_IEPA.d194.s467.p0", "text": "The PKC-specific inhibitors bisindolylmaleimide and Go 6976 abolish insulin-induced PLD2 activation in HEK-293 cells co-expressing the insulin receptor, PLCgamma and PLD2, confirming that not only PLD1, but PLD2 as well, is regulated in a PKC-dependent manner.", "text_with_entity_marker": "The PKC-specific inhibitors bisindolylmaleimide and Go 6976 abolish [E1]insulin[/E1]-induced PLD2 activation in HEK-293 cells co-expressing the insulin receptor, [E2]PLCgamma[/E2] and PLD2, confirming that not only PLD1, but PLD2 as well, is regulated in a PKC-dependent manner.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[68, 75]], "entity_1_idx_in_text_with_entity_marker": [72, 79], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLCgamma", "entity_2_idx": [[153, 161]], "entity_2_idx_in_text_with_entity_marker": [166, 174], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d195.s473_IEPA.d195.s473.p0", "text": "The addition of leptin to hypothalamic preparations from intact mice also did not alter NPY or CRH secretion", "text_with_entity_marker": "The addition of [E1]leptin[/E1] to hypothalamic preparations from intact mice also did not alter [E2]NPY[/E2] or CRH secretion", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[16, 22]], "entity_1_idx_in_text_with_entity_marker": [20, 26], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[88, 91]], "entity_2_idx_in_text_with_entity_marker": [101, 104], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
